Ebola Stocks Continue Higher

Loading...
Loading...
With over 700 already dead, the worst Ebola outbreak in history is pressuring the demand for development of new drugs to fight the Ebola virus. On Friday, The U.S. Food and Drug Administration said the agency stands ready to work with companies to develop drugs for patients "in dire need of treatment." Some of the companies that are likely to benefit include Tekmira Pharmaceuticals
TKMR
, Nano Vircides
NNVC
and BioChryst Pharamceuticals
BCRX
. Shares of all three companies were trading higher on the open, with TKMR up nearly 15% at 16.50.
Posted In: News
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...